An Indian trial (N=130) administered either bovine lactoferrin (with weight-based dosing) or placebo for the first 30 days of life and found a significant reduction in all sepsis events (p=0.001) and sepsis-attributable mortality (0.03) [47]. This evidence concerns the gene LTF and Sepsis.